Factors associated with choice of antipsychotic treatment in elderly veterans: Potential confounders for observational studies

Australian and New Zealand Journal of Public Health

Volumn 34, Issue 6, 2010, Pages 589-593

  Pratt, Nicole ^a   Roughead, Elizabeth ^b   Salter, Amy ^a   Ryan, Philip ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

Aged; Antipsychotic agents; Confounding factors; Dementia; Veterans

Indexed keywords

NEUROLEPTIC AGENT; PIPERAZINE DERIVATIVE;

AGED; ARTICLE; AUSTRALIA; CLINICAL PRACTICE; COMPARATIVE STUDY; DECISION MAKING; DEMENTIA; DRUG UTILIZATION; FEMALE; HUMAN; MALE; PSYCHOLOGICAL ASPECT; RISK FACTOR; SEX RATIO; STATISTICAL MODEL; STATISTICS; VETERAN;

AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; AUSTRALIA; CHOICE BEHAVIOR; DEMENTIA; DRUG UTILIZATION; FEMALE; HUMANS; MALE; MODELS, STATISTICAL; PHYSICIAN'S PRACTICE PATTERNS; PIPERAZINES; RISK FACTORS; SEX DISTRIBUTION; VETERANS;

EID: 79952278543     PISSN: 13260200     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1753-6405.2010.00613.x     Document Type: Article

References (28)

1. Ballard C, Waite J. The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease (Cochrane Review). In: The Cochrane Database Systematic Reviews. Issue 1, 2006. Chichester (UK): John Wiley and Sons; 2006.
2. De Deyn P P, Katz IR, Brodaty H, Lyons B, Greenspan A, Burns A. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone. Clin Neurol Neurosurg. 2005;107(6):497-508. (Pubitemid 41395226)
3. Hugenholtz G W, Heerdink ER, van Staa T P, Nolen WA, Egberts AC. Risk of hip/femur fractures in patients using antipsychotics. Bone. 2005;37(6):864-70. (Pubitemid 41773497)
4. Kolanowski A, Fick D, Waller JL, Ahern F. Outcomes of antipsychotic drug use in community-dwelling elders with dementia. Arch Psychiatr Nurs. 2006;20(5):217-25. (Pubitemid 44436834)
5. Liperoti R, Onder G, Lapane KL, Mor V, Friedman JH, Bernabei R, et al. Conventional or atypical antipsychotics and the risk of femur fracture among elderly patients: results of a case-control study. J Clin Psychiatry. 2007;68(6):929-34. (Pubitemid 47015494)
6. Normand SL, Sykora K, Li P, Mamdani M, Rochon PA, Anderson GM. Readers guide to critical appraisal of cohort studies: 3. Analytical strategies to reduce confounding. BMJ. 2005;330(7498):1021-3. (Pubitemid 40604289)
7. Knol W, van Marum RJ, Jansen PA, Souverein PC, Schobben AF, Egberts AC. Antipsychotic drug use and risk of pneumonia in elderly people. J Am Geriatr Soc. 2008;56(4):661-6. (Pubitemid 351473519)
8. Wada H, Nakajoh K, Satoh-Nakagawa T, Suzuki T, Ohrui T, Arai H, et al. Risk factors of aspiration pneumonia in Alzheimer's disease patients. Gerontology. 2001;47(5):271-6. (Pubitemid 32722285)
9. Department of Health and Ageing. Australian Statistics on Medicines. Canberra (AUST): Commonwealth of Australia; 2006.
10. Hollis J, Grayson D, Forrester L, Brodaty H, Touyz S, Cumming R. Antipsychotic medication dispensing and risk of death in veterans and war widows 65 years and older. Am J Geriatr Psychiatry. 2007;15(11):932-41.
11. Wang PS, Schneeweiss S, Avorn J, Fischer MA, Mogun H, Solomon DH, et al. Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med. 2005;353(22):2335-41. (Pubitemid 41713745)
12. Schneeweiss S, Setoguchi S, Brookhart A, Dormuth C, Wang PS. Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients. CMAJ. 2007;176(5):627-32. (Pubitemid 46426056)
13. Rochon PA, Gurwitz JH, Sykora K, Mamdani M, Streiner DL, Garfinkel S, et al. Reader's guide to critical appraisal of cohort studies: 1. Role and design. BMJ. 2005;330(7496):895-7. (Pubitemid 40545694)
14. Brookhart MA, Rassen JA, Wang PS, Dormuth C, Mogun H, Schneeweiss S. Evaluating the validity of an instrumental variable study of neuroleptics: can between-physician differences in prescribing patterns be used to estimate treatment effects? Med Care. 2007;45(10 Supl 2):S116-22.
15. Leader S, Mallick R, Roht L. Using medication history to measure confounding by indication in assessing calcium channel blockers and other antihypertensive therapy. J Hum Hypertens. 2001;15(3):153-9. (Pubitemid 32181479)
16. World Health Organization Collaborating Centre for Drug Statistics Methodology. Anatomical Therapeutic Chemical Code Classification Index with Defined Daily Doses [index on the Internet]. Oslo (NOR): Norwegian Institute of Public Health; 2009 [cited 2010 Mar. 12]. Available from: http://www.whocc.no/ atcddd/
17. PBS for Health Professionals. Schedule of Pharmaceutical Benefits [schedule on the Internet]. Canberra (AUST): Commonwealth Department of Health and Ageing; 2010 [cited 2010 Mar. 12]. Available from: http://www.pbs.gov.au/ html/healthpro/home
18. National Centre for Classification in Health. The International Statistical Classification of Diseases and Related Health Problems 10th revision Australian Modification (ICD-10-AM). 6th ed. Sydney (AUST): University of Sydney; 2005.
19. Vitry A, Wong SA, Roughead EE, Ramsay E, Barratt J. Validity of medicationbased co-morbidity indices in the Australian elderly population. Aust NZ J Public Health. 2009;33(2):126-30.
20. Stukel TA, Fisher ES, Wennberg DE, Alter DA, Gottlieb DJ, Vermeulen MJ. Analysis of observational studies in the presence of treatment selection bias: effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods. JAMA. 2007;297(3):278-85. (Pubitemid 46143305)
21. Whitaker HJ, Farrington C P, Spiessens B, Musonda P. Tutorial in biostatistics: the self-controlled case series method. Stat Med. 2006;25(10):1768-97.
22. Tsiropoulos I, Andersen M, Hallas J. Adverse events with use of antiepileptic drugs: a prescription and event symmetry analysis. Pharmacoepidemiol Drug Saf. 2009;18(6):483-91.
23. Greenland S. An introduction to instrumental variables for epidemiologists. Int J Epidemiol. 2000;29(6):1102.
24. Rassen JA, Brookhart MA, Glynn RJ, Mittleman MA, Schneeweiss S. Instrumental variables I: instrumental variables exploit natural variation in nonexperimental data to estimate causal relationships. J Clin Epidemiol. 2009;62(12):1226-32.
25. Pratt NL, Roughead EE, Salter A, Ryan, P. Antipsychotics and the risk of death in the elderly: An instrumental variable analysis using two preference based instruments. Pharmacoepidemiol Drug Saf. 2010;19(7):699-707.
26. Gill SS, Bronskill SE, Normand SL, Anderson GM, Sykora K, Lam K, et al. Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med. 2007;146(11):775-86. (Pubitemid 351650498)
27. Hollis J, Forrester L, Brodaty H, Touyz S, Cumming R, Grayson D. Risk of death associated with antipsychotic drug dispensing in residential aged care facilities. Aust N Z J Psychiatry. 2007;41(9):751-8. (Pubitemid 47261154)
28. De Deyn P P, Rabheru K, Rasmussen A, Bocksberger J P, Dautzenberg PL, Eriksson S, et al. A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia. Neurology. 1999;53(5):946-55. (Pubitemid 29442108)